20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Alnylam Pharmaceuticals (NASDAQ:ALNY) reported its Q3 earnings results on Thursday, October 27, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Alnylam Pharmaceuticals beat estimated earnings by 11.24%, reporting an EPS of $-1.58 versus an estimate of $-1.78.
Revenue was up $76.67 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.41 which was followed by a 1.03% drop in the share price the next day.
Here's a look at Alnylam Pharmaceuticals's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.62 | -1.84 | -1.54 | -1.57 |
| EPS Actual | -2.03 | -1.49 | -1.69 | -1.51 |
| Revenue Estimate | 255.88M | 243.02M | 233.62M | 218.69M |
| Revenue Actual | 224.82M | 213.26M | 258.54M | 187.63M |
To track all earnings releases for Alnylam Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!